The first Columbus program to test a new robotic methadone assembly machine

Using a new automated dose assembly machine, Registered Nurse Siv Mao removes a tray of methadone doses that will be dispensed to people with opioid use disorders.  CompDrug made history by being the first opioid treatment program to go live using Zing, which assembles doses automatically.  The innovative machine offers the opportunity to reduce human error, assemble drug doses at a rapid pace, and allow nursing staff to focus on direct patient care.

Siv Mao’s wrists ached as he twisted the lids on bottle after bottle of methadone every day at work. He would sit behind a window as patients approached, trying to chat with them and see how they were doing, while also focusing on measuring doses into bottles, printing and sticking labels, heat sealing them, and … Read more

Common Prescription Drugs Can Cause Depression as a Side Effect, Experts Say – UPI.com

Jacqui Henry, who said she now feels better than ever, developed depression after taking hormonal contraceptives for 15 years to manage the pain of endometriosis.  Photo courtesy of Jacqui Henry

1/5 Jacqui Henry, who said she now feels better than ever, developed depression after taking hormonal contraceptives for 15 years to manage the pain of endometriosis. Photo courtesy of Jacqui Henry NEW YORK, July 18 (UPI) — With some prescription drugs, treatment can be more serious than the underlying disease, as depression and even suicidal … Read more

Kabab Chini: What is its use and benefits?

chinese kabab

News Lifestyle Health Kabab Chini: What is its use and benefits? Certified nutritionist Dr Rohini Patil said it possesses antimicrobial properties and has been traditionally used to treat respiratory ailments (Source: Pixabay) NO,chinese kababit is not a literal cheeni-made kebab. An Indian grass vital to Ayurvedic and Unani medicine, kabab bend down Also known as … Read more

Many patients turn to online forums to vent about SSRIs

author['full_name']

Stopping or changing the dosage of selective serotonin reuptake inhibitors (SSRIs) may be more common than you might think, according to a qualitative study of online drug reviews. Out of 667 SSRI reviews posted on an online health forum by patients or healthcare professionals, 335 posts were about medication discontinuation, the most common type of … Read more

Despite deep discounts, Humira biosimilars are priced higher than the originator’s original price

Despite deep discounts, Humira biosimilars are priced higher than the originator's original price

Despite significant discounts from the current price of Humira (adalimumab), introductory prices of the biosimilars adalimumab are still double the originator’s introductory price, according to a study published in JAMA network open. Humira can be administered with a pre-filled syringe or an auto-injector pen. Throughout 2023, 9 FDA-approved adalimumab biosimilars are expected to enter the … Read more

What are the prospects for the Adalimumab biosimilar pipeline in dermatology

What are the prospects for the Adalimumab biosimilar pipeline in dermatology

In recent years, the evolving landscape of biosimilars has helped flood the market with a huge amount of information. In dermatology, biosimilars approvals have been pending since 2016 for adalimumab, a tumor necrosis factor inhibitor used to treat moderate to severe plaque psoriasis and hidradenitis suppurativa (HS); however, the former was only recently launched. Adalimumab-atto … Read more

Innovative Alzheimer’s drug slows disease: A new era for treatment

image of the brain

Medicinal From Marc Lallanilla July 17, 2023 | 10:53am A powerful and significant drug is offering new hope in the battle against Alzheimer’s disease, with scientists hailing it as a huge opportunity for patients with early-onset dementia. The innovative drug donanemab, developed by Eli Lilly, has had a successful clinical trial and is expected to … Read more

Akorn bankruptcy, shortages are cutting off patient access to generics

Akorn bankruptcy, shortages are cutting off patient access to generics

Representatives from the FDA and others appeared before Congress to express concern about severe financial strains plaguing the generic drug industry that have led to unprecedented drug shortages and supply chain disruptions.1.2 Empty Pill Bottle | Image credit: Yuriy Redkin-stock.adobe.com Generics account for about 90 percent of drug prescriptions in the United States, and shortages … Read more

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Filing for Rivoceranib in Combination with Camrelizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

Elevar Therapeutics Announces FDA Acceptance of New Drug Application Filing for Rivoceranib in Combination with Camrelizumab as First-Line Treatment for Unresectable Hepatocellular Carcinoma

FORT LEE, NJ, July 17, 2023 (GLOBE NEWSWIRE) — Elevar Therapeutics, Inc., a majority owned subsidiary of HLB Co., Ltd., is a fully integrated biopharmaceutical company dedicated to improving treatment experiences and patient outcomes who have limited or inadequate treatment options, announced today that the US Food and Drug Administration (FDA) has accepted a new … Read more